CD8A and cancer: CD8+PD-1+cells have been demonstrated in various cancers to contain tumor-reactive T cells25,35–39, and, to our knowledge, have not been described to be increased following NACT alone6,7,40, indicating that the increase in CD8+PD-1+ T cells is essentially promoted by PD-1 blockade.